Leaflet: information for the user
Strefen 8.75 mg lozenges, honey and eucalyptus flavor
Flurbiprofen
Read this leaflet carefully before you start taking this medicine, as it contains important information for you.
Follow exactly the administration instructions contained in this leaflet or those given by your doctor or pharmacist.
1. What Strefen is and what it is used for.
2. What you need to know before you start taking Strefen.
3. How to take Strefen.
4. Possible side effects.
5. Storage of Strefen.
6. Contents of the pack and additional information.
Strefencontainsflurbiprofeno. Theflurbiprofenobelongs to a group of medications called nonsteroidal anti-inflammatory drugs (NSAIDs) that have analgesic, antipyretic, and anti-inflammatory properties.Strefenis used for the occasional reliefof symptoms of sore throat such aspain,irritation,throat inflammation, anddifficulty swallowing in adults and adolescents 12 years of age and older.
You should consult a doctor if symptoms worsen or do not improve after3daysof treatment.
Do not takeStrefen:
Warnings and Precautions
Consult your doctor orpharmacist before starting to takeStrefenif:
Infections
Nonsteroidal anti-inflammatory drugs (NSAIDs) may mask signs of infection such as fever and pain. This may delay the start of appropriate treatment for the infection, leading to a higher risk of complications. If you take this medication while you have an infection and your symptoms persist or worsen, consult your doctor or pharmacist without delay.
While using Strefen
Children
This medication cannot be used by children under 12 years old.
Other medicationsandStrefen
Inform your doctor or pharmacist ifyou are taking, have taken recently or may need to take any other medication.
Taking Strefen with food, drinks and alcohol.
It is recommended to avoid consuming alcohol during treatment withthis medication, as it may increase the risk of stomach or intestinal bleeding.
Pregnancy,breastfeedingand fertility
If you are pregnant or breastfeeding,consult your doctor or pharmacist before usingthis medication.
Do not take this medication?if you are in the last trimester of pregnancy?Strefen. If you are in the first 6 months of pregnancy or breastfeeding, consult your doctor before taking this medication.
?
Flurbiprofen belongs to a group of medications that may alter fertility in women. This effect is reversible when the medication is stopped. It is unlikely that occasional use of this medication will affect your chances of becoming pregnant, but inform your doctor before taking this medication if you have difficulty conceiving.
Driving and operating machinery
No studies have been conducted on the effects of the medication on the ability to drive or operate machinery. However, dizziness and visual disturbances are possible side effects after taking NSAIDs. If you are affected, do not drive or operate machinery.
Strefencontainsisomalta(E953),maltitolliquid (E965) and fragrances withanisic alcohol, benzyl alcohol, benzyl benzoate, cinnamyl benzoate, benzyl salicylate, cinnamal, anisic alcohol, citral,geraniol, limoneneandlinalool.
This medication containsisomalta(E953)and maltitol liquid(E965). If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication may cause a mild laxative effect because it contains 2032.18 mgof Isomaltaper lozenge and 509.03 mg of maltitol liquidper lozenge.
Caloric value: 2.3 kcal/g of maltitol/isomalta.
Anisic alcohol, benzyl alcohol, benzyl benzoate, cinnamyl benzoate, benzyl salicylate, cinnamal, anisic alcohol, citral, geraniol, limonene and linaloolmay cause allergic reactions.
This medication contains 0.00169 mg of benzyl alcohol in each lozenge.
Consult your doctor or pharmacist if you are pregnant or breastfeeding (see section 2. Pregnancy, breastfeeding and fertility). This is because large amounts of benzyl alcohol may accumulate in your body and cause adverse effects (metabolic acidosis).
Benzyl alcohol may cause allergic reactions.
Follow exactly the administration instructions of this medication contained in this leaflet or those indicated by your doctor or pharmacist.In case of doubt, consult your doctor or pharmacist again.
The recommended dose in adults and adolescents 12 years and older is:
Use in children:
Children under 12 years old cannot take this medication.
These lozenges are only for short treatments.Use the lowest effective dose for the shortest time necessary to relieve symptoms. If you have an infection, consult a doctor or pharmacist without delay if symptoms (such as fever and pain) persist or worsen (see section 2). If mouth irritation appears, discontinue flurbiprofen treatment.
Do not take Strefen for more than 3 days, unless your doctor tells you to. If it does not improve, worsens, or new symptoms appear, consult your doctor or pharmacist.
If you take more Strefen than you should
Call a doctor or go to the nearest hospital immediately. Symptoms of overdose may include the following: nausea or vomiting, stomach pain or, less frequently, diarrhea, ringing in the ears, headache, and gastrointestinal bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20 indicating the medication and the amount ingested.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
If you forgot to take Strefen
Do not take a double dose to make up for the missed doses.
Like all medications, this medication may cause side effects, although not everyone will experience them.
STOP TAKING this medication and consult your doctor immediately if you notice:
Inform your doctor or pharmacist if you observe any of the following effects or any effect not described in this leaflet:
Frequent(may affect up to 1 in 10 people)
Rare(may affect up to 1 in 100 people)
Uncommon(may affect up to 1 in 1,000 people)
Unknown frequency(cannot be estimated from available data)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use:www.notificaram.es.
By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keepthis medicationout of the sight and reach of children.
Do not usethis medicationafter the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 25°C.
Medicines should not be thrown into the drains or trash. Dispose of the packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacisthow to dispose ofthepackaging and of themedications that you no longerneed.By doing so, you will help protect the environment.
The active ingredient (the component that makes the medicine effective) is flurbiprofen 8.75 mg. The other components (excipients) are: macrogol 300, potassium hydroxide (E525), ammonium caramel (E150c), curcumin (E100) (contains propylene glycol (E1520) and polisorbate 80), honey and eucalyptus aroma (contains preparations, natural flavorings, flavorings, triacetin (E1518), propylene glycol (E1520), anisic alcohol, benzyl alcohol, benzoate of benzyl, cinnamyl benzoate, salicylate of benzyl, cinnamal, cinnamyl alcohol, citral, geraniol, limonene, and linalol), acesulfame potassium (E950), liquid maltitol (E965), and isomalt (E953).
Appearance of the product and contents of the package
The lozenges are round, pale brown to yellow in color with the brand logo engraved, packaged in opaque PVC/PVdC/Aluminum blisters in a cardboard box with 16 lozenges.
Holder of the marketing authorization
Reckitt Benckiser Healthcare, S.A.
C/ Mataró, 28
08403 Granollers, Barcelona (Spain)
Responsible for manufacturing
RB NL Brands B.V.,
WTC Schiphol Airport,Schiphol Boulevard 207,
1118 BH Schiphol, Netherlands.
This medicine is authorized in the member states of the European Economic Area with the following names:
Germany | Dobendan Direkt Manuka Honig- & Eukalyptusgeschmack Flurbiprofen |
Austria | Strepsils Manukahonig- & Eukalyptusgeschmack Zuckerfrei8,75 mg Lutsch tabletten |
Belgium | Strepfen Honing & Eucalyptus 8.75 mg zuigtabletten |
Bulgaria | Strepsils Intensive Honey and Eucalyptus Sugar Free 8,75 mg lozenges ?????????????????????????????????? ????? 8.75 mg ???????? ?? ??????? |
Cyprus | Strepfen Manuka Honey and Eucalyptus Sugar-Free lozenge, 8.75 mg/loz |
Croatia | Strepfen bez šecera s okusom meda i eukaliptusa 8,75 mg pastile |
Denmark | Strefen Honning og Eukalyptus Sukkerfri |
Slovakia | Strepfen Manuka Med a Eukalyptus bez cukru |
Slovenia | Strepfen brez sladkorja z okusom medu in evkalipta 8,75 mg pastile |
Spain | Strefen 8,75 mg pastillas para chupar sabor miel y eucalipto |
Estonia | Strepfen Manuka Honey & Eucalyptus |
Finland | Strefen Honey & Eucalyptus 8,75 mg imeskelytabletti |
Greece | Strepfen Manuka Honey and Eucalyptus Sugar-Free lozenge, 8.75 mg/loz |
Hungary | Strepfen méz és eukaliptusz 8,75 mg szopogató tabletta |
Iceland | Strefen Honning og Eukalyptus Sukkerfri 8,75 mg munnsogstöflur |
Latvia | Strefen 8,75 mg sukajamas tabletes |
Luxembourg | Strepfen arôme Manuka & Eucalyptus Sans Sucre 8,75 mg pastilles |
Norway | Strefen |
Netherlands | Strepfen met Honing- & Eucalyptussmaak Suikervrij 8,75 mg, zuigtabletten |
Poland | Strepsils Intensive o smaku miodu i eukaliptusa |
Portugal | Strepfen Mel de Manuca e Eucalipto sem açúcar, 8,75 mg pastilhas |
Czech Republic | Strepfen Med a Eukalyptus bez cukru |
Romania | Strepsils Intensiv Miere ?i Eucaliptfara zahar 8,75 mg pastile |
Sweden | Strefen Honung & Eukalyptus 8,75 mg sugtabletter |
Last review date of this leaflet: February 2024
The detailed information of this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.